| Insulin resistance in essential hypertension E Ferrannini, G Buzzigoli, R Bonadonna, MA Giorico, M Oleggini, ... New England Journal of Medicine 317 (6), 350-357, 1987 | 3111 | 1987 |
| Pathogenesis of NIDDM: a balanced overview RA DeFronzo, RC Bonadonna, E Ferrannini Diabetes care 15 (3), 318-368, 1992 | 2833 | 1992 |
| Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance … E Bonora, G Targher, M Alberiche, RC Bonadonna, F Saggiani, ... Diabetes care 23 (1), 57-63, 2000 | 2670 | 2000 |
| Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, ... Diabetes 47 (10), 1643-1649, 1998 | 1228 | 1998 |
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. LC Groop, RC Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, ... The Journal of clinical investigation 84 (1), 205-213, 1989 | 881 | 1989 |
| HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study E Bonora, G Formentini, F Calcaterra, S Lombardi, F Marini, L Zenari, ... Diabetes care 25 (7), 1135-1141, 2002 | 583 | 2002 |
| Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning R Weiss, S Dufour, SE Taksali, WV Tamborlane, KF Petersen, ... The Lancet 362 (9388), 951-957, 2003 | 567 | 2003 |
| Insulin causes endothelial dysfunction in humans: sites and mechanisms G Arcaro, A Cretti, S Balzano, A Lechi, M Muggeo, E Bonora, ... Circulation 105 (5), 576-582, 2002 | 562 | 2002 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 547 | 2018 |
| Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, RC Bonadonna, ... Diabetes care 26 (4), 1251-1257, 2003 | 453 | 2003 |
| Obesity and insulin resistance in humans: a dose-response study RC Bonadonna, G Leif, N Kraemer, E Ferrannini, S Del Prato, ... Metabolism 39 (5), 452-459, 1990 | 450 | 1990 |
| The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study E Bonora, G Targher, G Formentini, F Calcaterra, S Lombardi, F Marini, ... Diabetic Medicine 21 (1), 52-58, 2004 | 390 | 2004 |
| Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. M Muggeo, G Zoppini, E Bonora, E Brun, RC Bonadonna, P Moghetti, ... Diabetes care 23 (1), 45-50, 2000 | 389 | 2000 |
| The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus LC Groop, C Saloranta, M Shank, RC BONADONNA, E Ferrannini, ... The Journal of Clinical Endocrinology & Metabolism 72 (1), 96-107, 1991 | 382 | 1991 |
| Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the … E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, JB Meigs, ... Diabetes care 30 (2), 318-324, 2007 | 355 | 2007 |
| Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, JB Meigs, ... Diabetes 53 (7), 1782-1789, 2004 | 347 | 2004 |
| Phasic insulin release and metabolic regulation in type 2 diabetes S Del Prato, P Marchetti, RC Bonadonna Diabetes 51 (suppl 1), S109-S116, 2002 | 339 | 2002 |
| Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control E Bonora, F Calcaterra, S Lombardi, N Bonfante, G Formentini, ... Diabetes care 24 (12), 2023-2029, 2001 | 329 | 2001 |
| Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, RC Bonadonna, ... International journal of obesity 27 (10), 1283-1289, 2003 | 287 | 2003 |
| Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects S Bevilacqua, R Bonadonna, G Buzzigoli, C Boni, D Ciociaro, F Maccari, ... Metabolism 36 (5), 502-506, 1987 | 285 | 1987 |
enzo bonoraProfessore Ordinario di Endocrinologia, Università di Verona, ItalyVerified email at univr.it
